Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from DocMorris ( (CH:DOCM) ).
DocMorris Finance B.V., a subsidiary of DocMorris AG, has exercised its option to redeem early its 6.875% convertible bond due in September 2026, following previous buybacks that reduced the outstanding nominal amount to around CHF 8 million, well below the 15% threshold set in the bond terms. The remaining bonds will be repaid at nominal value plus 80 days’ accrued interest on 5 March 2026, with the last trading day on SIX Swiss Exchange set for 3 March 2026, while bondholders retain the right to convert their holdings into DocMorris shares until 19 February 2026, though the conversion price is significantly above the current share price, making cash repayment the more likely outcome and simplifying the company’s capital structure.
The most recent analyst rating on (CH:DOCM) stock is a Hold with a CHF5.50 price target. To see the full list of analyst forecasts on DocMorris stock, see the CH:DOCM Stock Forecast page.
More about DocMorris
DocMorris AG is a Swiss-listed digital health company active in online pharmacy, telemedicine and health-product marketplaces, with strong brands in Germany and other European countries. Operating mainly from an automated logistics centre in Heerlen, Netherlands, and via Germany’s TeleClinic platform with over 6,000 doctors, DocMorris also runs leading marketplaces in Southern Europe and in 2025 generated CHF 1,186 million in external sales from 11 million active customers across six countries.
Average Trading Volume: 330,376
Technical Sentiment Signal: Sell
Current Market Cap: CHF272.2M
For detailed information about DOCM stock, go to TipRanks’ Stock Analysis page.